Latest articles from Cancer Therapy Advisor Male Reproductive Cancers
Detection of a specific germline alteration in HSD3B1 may help oncologists gauge the potential benefit of upfront abiraterone or ADT in Japanese patients with prostate cancer. from Latest articles from Cancer Therapy Advisor Ma…
Concerns about conflict of interest as it relates to prescribing may never go away, some say, as long as drug companies offer doctors money for consulting and personal services. from Latest articles from Cancer Therapy Advisor …
In a statement announcing a newly created partnership, the Botanical Safety Consortium, FDA Commissioner Scott Gottlieb made no mention of cannabidiol. from Latest articles from Cancer Therapy Advisor Male Reproductive Cancers …
Among men with nonmetastatic castration-resistant prostate cancer, those who were treated with darolutamide had a 59% decreased risk of metastasis compared with placebo recipients. from Latest articles from Cancer Therapy Advis…
After an additional 1 year of follow-up, apalutamide plus ADT continued to show a significant decrease in the risk of progression to metastasis or death. from Latest articles from Cancer Therapy Advisor Male Reproductive Cancer…
At 23 years of follow-up, the cumulative incidence of death was higher among patients in the watchful waiting group compared with those in the radical prostatectomy group. from Latest articles from Cancer Therapy Advisor Male R…
The study is the first to show that treatment with abiraterone acetate/enzalutamide is associated with better survival in African American patients with mCRPC compared with Caucasians. from Latest articles from Cancer Therapy A…
By targeting prostate-specific membrane antigen, a molecule radiolabeled with lutetium-177 is expected to deliver high doses of beta radiation to distant metastases. from Latest articles from Cancer Therapy Advisor Male Reprodu…
The Decipher genomic classifier predicted metastases and prostate cancer-specific mortality following radical prostatectomy with greater precision in African-American men. from Latest articles from Cancer Therapy Advisor Male R…
"People have shown that the variant-identification quality of WGS is superior to WES," said Dr Gerstein. from Latest articles from Cancer Therapy Advisor Male Reproductive Cancers http://bit.ly/2Ib0XoE
Patients with metastatic CRPC and bone metastases treated with abiraterone plus prednisone/prednisolone had a higher risk of bone fractures when receiving concomitant radium-223. from Latest articles from Cancer Therapy Advisor…
From 2010 to 2015, active surveillance/watchful waiting increased from 14.5% to 42.1%, according to a new study. from Latest articles from Cancer Therapy Advisor Male Reproductive Cancers http://bit.ly/2TNJkfS
Patient-reported outcomes, or PROs, are going to play a larger role in FDA cancer drug approvals, according to an expert in the field. from Latest articles from Cancer Therapy Advisor Male Reproductive Cancers http://bit.ly/2SI…
A high percentage of men with prostate cancer have 1 or more potentially pathogenic germline variants, but would not be eligible for mutation testing under current NCCN guidelines. from Latest articles from Cancer Therapy Advis…
Articles discussing the use of cannabis as a substitute for opioids highlight the limitations of the existing scientific evidence in the field. from Latest articles from Cancer Therapy Advisor Male Reproductive Cancers http://b…
The continuous decline in cancer deaths over the past 25 years was attributed to improvements in screening, treatment. from Latest articles from Cancer Therapy Advisor Male Reproductive Cancers http://bit.ly/2HXijVI
Experts examined the role of population-based early detection cancer screening. from Latest articles from Cancer Therapy Advisor Male Reproductive Cancers http://bit.ly/2HPQ3ED
Researchers are excited about the prospect to use vaccines in combination with checkpoint inhibitors to improve the body's cancer-fighting ability. from Latest articles from Cancer Therapy Advisor Male Reproductive Cancers …
QoL for patients with cancer is reduced just as much by the accumulation of low-level toxicities as it is from high-level adverse events. from Latest articles from Cancer Therapy Advisor Male Reproductive Cancers http://bit.ly/…
Almac Diagnostics has published analytical validation of a 70-gene assay designed for use with formalin-fixed paraffin-embedded samples from Latest articles from Cancer Therapy Advisor Male Reproductive Cancers http://bit.ly/2H…
